These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report. Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392 [TBL] [Abstract][Full Text] [Related]
12. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report. Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273 [TBL] [Abstract][Full Text] [Related]
13. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis. Martini N; Rizzo S; Sarais C; Cipriani A BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442 [TBL] [Abstract][Full Text] [Related]
14. "Loss of Bone Signal" on 99m Tc-Labeled Pyrophosphate Scintigraphy in a Patient With Wild-Type Transthyretin Amyloidosis. Takahashi K; Sasaki D; Iwamura T; Sakaue T; Okura T Clin Nucl Med; 2024 Aug; 49(8):767-770. PubMed ID: 38651784 [TBL] [Abstract][Full Text] [Related]
15. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis]. Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088 [TBL] [Abstract][Full Text] [Related]